Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 28, 2021, titled "Dr. Reddy's Laboratories receives DCGI approval tolaunch Molnupiravir capsules 200mg (Molflu ) in India".
Press Release Dec 28 2021
Filed with NSE · · 2 pages · English
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings CallRelease
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Dec 09 2021
- Press Release Oct 29 2021
- Press Release Oct 19 2021
- Press Release Oct 15 2021
- Press Release Oct 14 2021
Later from Dr. Reddy's Laboratories
- Press Release Jan 17 2022
- Press Release Feb 02 2022
- Press Release Feb 03 2022
- Press Release Feb 07 2022
- Press Release Feb 09 2022
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories